ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Docetaxel Injection shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting Feb 20, 2026 · last update Feb 20, 2026

Manufacturers: Ingenus Pharmaceuticals LLC

Stated reasons (per FDA): Not stated

More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08)Ingenus Pharmaceuticals LLCTo Be Discontinued
—A business decision was made to discontinue manufacture of the drug.Posted Feb 20, 2026
Updated Feb 20, 2026
Discontinued Feb 20, 2026
Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16)Ingenus Pharmaceuticals LLCTo Be Discontinued
—A business decision was made to discontinue manufacture of the drug.Posted Feb 20, 2026
Updated Feb 20, 2026
Discontinued Feb 20, 2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)

Free, weekly, unsubscribe anytime. Privacy.